![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2021
Aughton, Karen; Elander, Nils O.; Evans, Anthony; Jackson, Richard; Campbell, Fiona; Costello, Eithne; Halloran, Christopher M.; Mackey, John R.; Scarfe, Andrew G.; Valle, Juan W.; Carter, Ross; Cunningham, David; Tebbutt, Niall C.; Goldstein, David; Shannon, Jennifer; Glimelius, Bengt; Hackert, Thilo; Charnley, Richard M.; Anthoney, Alan; Lerch, Markus M.; Mayerle, Julia; Palmer, Daniel H.; Buechler, Markus W.; Ghaneh, Paula; Neoptolemos, John P. und Greenhalf, William
(2021):
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA.
In: Cancers, Bd. 13, Nr. 22, 5758
2020
de Bono, Johann; Lin, Chia-Chi; Chen, Li-Tzong; Corral, Jesus; Michalarea, Vasiliki; Rihawi, Karim; Ong, Michael; Lee, Jih-Hsiang; Hsu, Chih-Hung; Yang, James Chih-Hsin; Shiah, Her-Shyong; Yen, Chia-Jui; Anthoney, Alan; Jove, Maria; Buschke, Susanne; Fuertig, Rene; Schmid, Ulrike; Goeldner, Rainer-Georg; Strelkowa, Natalja; Huang, Dennis Chin-Lun; Bogenrieder, Thomas; Twelves, Chris und Cheng, Ann-Lii
(2020):
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours.
In: British Journal of Cancer, Bd. 122, Nr. 9: S. 1324-1332
2019
Jones, Robert P.; Psarelli, Eftychia-Eirini; Jackson, Richard; Ghaneh, Paula; Halloran, Christopher M.; Palmer, Daniel H.; Campbell, Fiona; Valle, Juan W.; Faluyi, Olusola; O'Reilly, Derek A.; Cunningham, David; Wadsley, Jonathan; Darby, Suzanne; Meyer, Tim; Gillmore, Roopinder; Anthoney, Alan; Lind, Pehr; Glimelius, Bengt; Falk, Stephen; Izbicki, Jakob R.; Middleton, Gary William; Cummins, Sebastian; Ross, Paul J.; Wasan, Harpreet; McDonald, Alec; Crosby, Tom; Ting, Yuk; Patel, Kinnari; Sherriff, David; Soomal, Rubin; Borg, David; Sothi, Sharmila; Hammel, Pascal; Lerch, Markus M.; Mayerle, Julia; Tjaden, Christine; Strobel, Oliver; Hackert, Thilo; Buchler, Markus W.; Neoptolemos, John P.; Hill, Mark; Corrie, Pippa; Hickish, Tamas; Napier, Mark; Slater, Sarah; Valle, Juan; Shablak, Alaaeldin; Cunnell, Michelle; Guimbaud, Rosine; Roques, Tom; Iveson, Tim; Jamil, Arshad; Robinson, Angus; Garcia-Alonso, Angel; Chang, David; Tsang, David; Wadd, Nick; Wall, Lucy; Nielsen, Niels Hilmer; Lerch, Markus; Mehta, Ajay; Sivaramalingam, Muthiah; Fyfe, David; Osborne, Richard; Blesing, Claire; Bulusu, Venkata Ramesh; Rathbone, Emma; Seitz, Jean-Francois; Beaumont, Erica; Dernedde, Ulrike; McAdam, Karen; Dimopoulos, Prokopios; Cominos, Mathilda; Askill, Colin; Piwowar, Andrzej; Bachet, Jean-Baptiste; Sumpter, Kate; Raouf, Sherif; Nicoll, Jonathan; Rees, Charlotte; Dhinakaran, Kathirvelu; Haux, Johan; Bengrine-Lefevre, Leila; Terrebonne, Eric; Shankland, Catherine; Palmer, Cheryl; Medley, Louise; Toy, Elizabeth; Kaur, Jasvinder; Gupta, Kamalnayan; Cheeseman, Sue; Patterson, Daniel; Candish, Charles; Thompson, Joyce; Coxon, Fareeda; Connolly, Caroline; McPhail, Neil; Williams, Rachel; Flygare, Petra; Elmlund, Mattias; Artru, Pascal und Millat, Bertrand
(2019):
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.
In: Jama Surgery, Bd. 154, Nr. 11: S. 1038-1048
2018
Elander, N. O.; Aughton, K.; Ghaneh, P.; Neoptolemos, J. P.; Palmer, D. H.; Cox, T. F.; Campbell, F.; Costello, E.; Halloran, C. M.; Mackey, J. R.; Scarfe, A. G.; Valle, J. W.; McDonald, A. C.; Carter, R.; Tebbutt, N. C.; Goldstein, D.; Shannon, J.; Dervenis, C.; Glimelius, B.; Deakin, M.; Charnley, R. M.; Anthoney, Alan; Lerch, M. M.; Mayerle, J.; Olah, A.; Büchler, M. W. und Greenhalf, W.
(2018):
Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer.
In: British Journal of Cancer, Bd. 118, Nr. 7: S. 947-954
2017
Schoffski, Patrick; Wozniak, Agnieszka; Escudier, Bernard; Rutkowski, Piotr; Anthoney, Alan; Bauer, Sebastian; Sufliarsky, Jozef; Herpen, Carla van; Lindner, Lars H.; Grünwald, Viktor; Zakotnik, Branko; Lerut, Evelyne; Debiec-Rychter, Maria; Marreaud, Sandrine; Lia, Michela; Raveloarivahy, Tiana; Collette, Sandra und Albiges, Laurence
(2017):
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial.
In: European Journal of Cancer, Bd. 87: S. 147-163